123 related articles for article (PubMed ID: 6276143)
1. Dopaminergic inhibition of pituitary beta-endorphin-like immunoreactivity secretion in the rat.
Farah JM; Malcolm DS; Mueller GP
Endocrinology; 1982 Feb; 110(2):657-9. PubMed ID: 6276143
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and dopamine independently regulate pituitary beta-endorphin release in vivo.
Sapun-Malcolm D; Farah JM; Mueller GP
Neuroendocrinology; 1986; 42(3):191-6. PubMed ID: 3005900
[TBL] [Abstract][Full Text] [Related]
3. Evidence that a serotonergic mechanism stimulates the secretion of pituitary beta-endorphin-like immunoreactivity in the rat.
Sapun DI; Farah JM; Mueller GP
Endocrinology; 1981 Aug; 109(2):421-6. PubMed ID: 6265189
[TBL] [Abstract][Full Text] [Related]
4. Evidence that a benzodiazepine receptor mechanism regulates the secretion of pituitary beta-endorphin in rats.
Maiewski SF; Larscheid P; Cook JM; Mueller GP
Endocrinology; 1985 Aug; 117(2):474-80. PubMed ID: 2990851
[TBL] [Abstract][Full Text] [Related]
5. Opiate modulation of the anterior pituitary hormone response during suckling in the rat.
Riskind PN; Millard WJ; Martin JB
Endocrinology; 1984 Apr; 114(4):1232-7. PubMed ID: 6323136
[TBL] [Abstract][Full Text] [Related]
6. Evidence for independent secretion of beta-endorphin immunoreactivity from rat pars distalis in vivo.
Pettibone DJ; Mueller GP
Endocrinology; 1982 Feb; 110(2):469-73. PubMed ID: 6276137
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat.
Millington WR; O'Donohue TL; Mueller GP
J Pharmacol Exp Ther; 1987 Oct; 243(1):160-70. PubMed ID: 2959768
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH
Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
Van Loon GR; De Souza EB; Shin SH
Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
[TBL] [Abstract][Full Text] [Related]
10. The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the rat.
Millard WJ; Sagar SM; Badger TM; Carr DB; Arnold MA; Spindel E; Kasting NW; Martin JB
Endocrinology; 1983 Feb; 112(2):518-25. PubMed ID: 6184215
[TBL] [Abstract][Full Text] [Related]
11. Effect of histamine and its blockers on plasma beta-endorphin-like immunoreactivity in rats.
Mitsuma T; De Heng S; Nogimori T; Chaya M; Hirooka Y; Ohtake K
Endocrinol Exp; 1987 Jun; 21(2):95-102. PubMed ID: 2956084
[TBL] [Abstract][Full Text] [Related]
12. A D-2 dopaminergic agonist stimulates secretion of anterior pituitary immunoreactive beta-endorphin in rats.
Farah JM; Mueller GP
Neuroendocrinology; 1989 Jul; 50(1):26-32. PubMed ID: 2569171
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for the stimulatory effects of opioidergic and serotonergic input signals on prolactin in pregnant rats.
Sagrillo CA; Voogt JL
Life Sci; 1992; 50(20):1479-89. PubMed ID: 1579043
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
15. Evidence for serotonergic stimulation of pituitary beta-endorphin release: preferential release from the anterior lobe in vivo.
Sapun-Malcolm D; Farah JM; Mueller GP
Life Sci; 1983 Jul; 33(1):95-102. PubMed ID: 6306375
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic control of immunoreactive beta-endorphin release from the pituitary of the rat: in vitro and in vivo studies.
Pettibone DJ; Mueller GP
J Pharmacol Exp Ther; 1982 Jul; 222(1):103-8. PubMed ID: 6283065
[TBL] [Abstract][Full Text] [Related]
17. The effects of GnRH and adrenergic agents on PRL and beta-endorphin secretion by porcine pituitary cells in vitro.
Siawrys G; Bogacka I; Okrasa S; Kamiński T; Przała J
Acta Vet Hung; 2003; 51(3):353-69. PubMed ID: 14516163
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Canonico PL; Valdenegro CA; MacLeod RM
Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
[TBL] [Abstract][Full Text] [Related]
19. Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.
López FJ; Dominguez JR; Sánchez-Franco F; Negro-Vilar A
Endocrinology; 1989 Jan; 124(1):527-35. PubMed ID: 2909379
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic treatment with haloperidol on serum prolactin, striatal opiate receptors and beta-endorphin content in rat brain and pituitary.
Kato N; Shah KR; Friesen HG; Havlicek V
Prog Neuropsychopharmacol; 1981; 5(5-6):549-52. PubMed ID: 6280225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
